More on DCOY
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.58 |
|
|||
| Open | $0.54 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.64 | ||||
| Day Low | $0.53 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 166,605 | ||||
- Form 8-K Decoy Therapeutics Inc. For: Mar 05
- Decoy Therapeutics implements 1-for-12 reverse stock split
- Decoy Therapeutics Announces 1-for-12 Reverse Stock Split
- Form 8-K Decoy Therapeutics Inc. For: Feb 24
- Form SCHEDULE 13G/A Decoy Therapeutics Inc. Filed by: CVI Investments, Inc.
- Decoy Therapeutics joins Webull corporate communication platform
- Decoy Therapeutics Joins Webull Corporate Connect Service Platform
- Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
- Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement
- Ladenburg Thalmann Starts Decoy Therapeutics Inc. (DCOY) at Buy
Entities mentioned with DCOY
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Ladenburg Thalmann Financial Services | View Related Stories »
- 13G | View Related Stories »
- Show More...
